duphaston 10 milligram film coated tablet
bgp products ltd - dydrogesterone - film coated tablet - 10 milligram - pregnadien derivatives - urinary system and sex hormones - in the management of conditions associated with progesterone insufficiency: dysmenorrhoea, endometriosis, infertility, irregular menstrual cycles and pre-menstrual syndrome. the drug may be used with an estrogen in the management of dysfunctional bleeding or secondary amenorrhoea, or in association with estrogen in hormone replacement therapy.
lipantil micro 67 milligram capsules hard
bgp products ltd - fenofibrate - capsules hard - 67 milligram - fibrates - serum lipid reducing agents/cholesterol and triglyceride reducers/fibrates - it is indicated as an adjunct to diet and other non-pharmacological treatment (e.g. exercise, weight reduction) for the following: - treatment of severe hypertriglyceridaemia with or without low hdl cholesterol. - mixed hyperlipidaemia when a statin is contraindicated or not tolerated. - mixed hyperlipidaemia in patients at high cardiovascular risk in addition to a statin when triglycerides and hdl cholesterol are not adequately controlled.
lipantil micro 200mg capsules, hard.
bgp products ltd - fenofibrate. - capsule, hard. - 200mg - serum lipid reducing agents/cholesterol and triglyceride reducers/fibrates - it is indicated as an adjunct to diet and other non-pharmacological treatment (e.g. exercise, weight reduction) for the following: - treatment of severe hypertriglyceridaemia with or without low hdl cholesterol. - mixed hyperlipidaemia when a statin is contraindicated or not tolerated. - mixed hyperlipidaemia in patients at high cardiovascular risk in addition to a statin when triglycerides and hdl cholesterol are not adequately controlled.
lipantil supra 145 milligram film coated tablet
bgp products ltd - fenofibrate - film coated tablet - 145 milligram - fibrates - serum lipid reducing agents / cholesterol and triglycerides reducers / fibrates - it is indicated as an adjunct to diet and other non-pharmacological treatment (e.g. exercise, weight reduction) for the following: treatment of severe hypertriglyceridaemia with or without low hdl cholesterol. mixed hyperlipidaemia when a statin is contraindicated or not tolerated. mixed hyperlipidaemia in patients at high cardiovascular risk in addition to a statin when triglycerides and hdl cholesterol are not adequately controlled.
serc 8 milligram tablets
bgp products ltd - betahistine hydrochloride - tablets - 8 milligram - antivertigo preparations - anti-vertigo preparations - vertigo, tinnitus and hearing loss associated with ménière's syndrome
serc 16 milligram tablets
bgp products ltd - betahistine hydrochloride - tablets - 16 milligram - antivertigo preparations - anti-vertigo preparations - vertigo, tinnitus and hearing loss associated with ménière's syndrome.
betahecon 8 milligram tablets
bgp products ltd - betahistine dihydrochloride - tablets - 8 milligram - antivertigo preparations
betahecon 16 milligram tablets
bgp products ltd - betahistine dihydrochloride - tablets - 16 milligram - antivertigo preparations
femoston 1 mg, 10 m milligram film coated tablet
bgp products ltd - estradiol hemihydrate, dydrogesterone - film coated tablet - 1 mg, 10 m milligram - progestogens and estrogens, sequential preparations
femoston-conti 0.5/2.5 milligram film coated tablet
bgp products ltd - estradiol, dydrogesterone - film coated tablet - 0.5/2.5 milligram - progestogens and estrogens, fixed combinations